Sunscreen Group Remains Cloudy About FDA's Ingredient Evaluations
This article was originally published in The Pink Sheet
Executive Summary
PASS Coalition fails to find common ground with US FDA as the sunscreen access advocacy group urges significant changes to a draft guidance on safety testing for sunscreen ingredients.
You may also be interested in...
Manufacturers Argue FDA Sunscreen Reviews Keep Outside Science In Shade
FDA officials and the Public Access to Sunscreen Coalition will meet Nov. 1 in effort to find common ground between FDA and outside scientists on standards for testing requirements of new sunscreens under one of four draft guidances the agency is scheduled to finalize by the end of the year.
Sunscreen Guidances Underscore FDA Standards Aren’t Changing
CDER has published guidances, required by the 2014 Sunscreen Innovation Act, on FDA’s process for advisory committees to consider firms’ sunscreen ingredient proposals and on withdrawing pending proposals being considered by the agency.
Sunscreen Trade Groups Urge 'Modern' Risk Assessments For Ingredients
FDA should revise its draft guidance on OTC sunscreen GRASE data to reflect modern toxicological risk assessment, CHPA and PCP say.